Soy, its components, and cancer prevention: A review of the in vitro, animal, and human data

Cancer Epidemiology Biomarkers and Prevention

Volumn 7, Issue 11, 1998, Pages 1055-1065

  Fournier, David B ^a   Erdman Jr , John W ^b   Gordon, Gary B ^a  

^a PFIZER INC   (United States)

^b UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENISTEIN; ISOFLAVONE; PHYTIC ACID; PROTEINASE INHIBITOR; SAPONIN;

BREAST CANCER; CANCER INCIDENCE; CANCER PREVENTION; COLON CANCER; DIET; DIETARY INTAKE; PRIORITY JOURNAL; PROSTATE CANCER; REVIEW; SOYBEAN;

ANIMALS; ANTICARCINOGENIC AGENTS; HUMANS; NEOPLASMS; NEOPLASMS, EXPERIMENTAL; PHYTOTHERAPY; SOYBEANS;

EID: 0031734143     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (138)

1. American Cancer Society. Facts and Figures 1994, Atlanta, GA.
2. Parkin, D. M Cancers of the breast, endometrium and ovary: geographic correlations. Eur. J. Cancer Clin Oncol., 25: 1917-1923, 1989.
3. Doll, R. The epidemiology of cancer. Cancer (Phila.), 45: 2475-2485, 1980.
4. Doll, R., and Pcto, R. The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. J. Natl Cancer Inst., 66. 1193-1308, 1981.
5. Barnes, S., Peterson, G. T., and Coward, L Rationale for the use of genistein-containing matrices in chemoprevention trials for breast and prostate cancer. J. Cell. Biochem. Suppl., 22: 181-187, 1995.
6. Miller, A. B., Berrino, F , Hill, M., Pietinen, P , Riboli, E , and Wahrendorf, J. Diet in the aetiology of cancer a review. Eur. J. Cancer, 30A: 207-220, 1994
7. Goodman, M. T., Nomura, A. M. Y., Wilkens, L. R., and Hankin, J The association of diet, obesity, and breast cancer in Hawaii. Cancer Epidemiol. Biomark. Prev., 1. 269-275, 1992.
8. Messina, M. J., Persky, V , Setchell, K. D., and Barnes, S. Soy intake and cancer risk: a review of the in vitro and in vivo data. Nutr. Cancer, 21: 113-131, 1994.
9. Adlercreutz, C. H. T., Goldin, B. R., Gorbach, S. L , Hockerstedt, K. A., Watanabe, S., Hämäläinen, E. K., Markkanen, M. H., Mäkelä, T. H., and Wahälä, K. T., Hase, T. A., and Fotsis, T. Soybean phytoestrogen intake and cancer risk. J. Nutr, 125: 757S-770S, 1995
10. Barnes, S. Effect of genistein on in vitro and in vivo models of cancer J. Nutr., 125: 777S-783S, 1995.
11. Kurzer, M. S., and Xu, X. Dietary phytoestrogens Annu. Rev. Nutr., 17: 353-381, 1997.
12. Adlercreutz, H. Evolution, nutrition, intestinal microflora, and prevention of cancer: a hypothesis Proc. Soc. Exp Biol. Med , 217 241-246, 1998
13. Kudou, S., Fleury, Y., Welt, D., Magnolato, D , Uchida, T., Kitamura, K., and Okubo, K. Malonyl isoflavone glycosides in soybean seeds (Glycine max Merrill). Agric. Biol. Chem., 55: 2227-2233, 1991.
14. Coward, L, Barnes, N. C., Setchell, K. D. R, and Barnes, S Genistein, daidzein, and their β-glycoside conjugates: antitumor isoflavones in soybean foods from American and Asian diets. J Agric. Food Chem, 41 1961-1967, 1993.
15. Wang, H-J., and Murphy, P. A. Isoflavone content in commercial soybean foods. J Agric. Food Chem., 42: 1666-1673, 1994.
16. Franke, A. A., Custer, L. J., Cerna, C. M., and Narala, K. K. Quantitation of phytoestrogens in legumes by HPLC. J. Agric. Food Chem., 42: 1905-1913, 1994.
17. Fukutake, M., Takahashi, M., Ishida, K., Kawamura, H., Sugimura, T., and Wakabayashi, K Quantification of genistein and genistin in soybeans and soybean products Food Chem. Toxicol., 34: 457-461, 1996.
18. Martin, P. M , Horwitz, K B., Ryan, D. S , And McGuire, W L. Phytoestrogen interaction with estrogen receptors in human breast cancer cells Endocrinology, 103: 1860-1867, 1978.
19. Makishima, M., Honma, Y., Hozumi, M., Sampi, K., Hattori, M., Umezawa, K , and Motoyoshi, K Effects of inhibitors of protein tyrosine kinase activity and/or phosphatidylinositol turnover on differentiation of some human myelomonocytic leukemia cells. Leuk. Res., 15: 701-708, 1991
20. Carlo Stella, C., Regazzi, E., Garau, D., Mangoni, L , Rizzo, M T , Bonati, A., Dotti, G., Almici, C , and Rizzoli, V. Effect of the protein tyrosine kinase inhibitor genistein on normal and leukaemic haemopoietic progenitor cells. Br J. Haematol, 93: 551-557, 1996.
21. Linassier, C, Pierre, M., Le Pecq, J-B , and Pierre, J. Mechanisms of action in NIH-3T3 cells of genistein, an inhibitor of EGF receptor tyrosine kinase activity. Biochem. Pharmacol, 39: 187-193, 1990.
22. Akiyama, T , Ishida, J., Nakagawa, S , Ogawara, H., Watanabe, S., Itoh, N., Shibuya, M , and Fukami, Y. Genistein, a specific inhibitor of tyrosine-specific protein kinases. J. Biol. Chem , 262. 5592-5595, 1987
23. Okura, A., Arakawa, H., Oka, H , Yoshinari, T., and Monden, Y. Effect of genistein on topoisomerase activity and on the growth of [Val 12]Ha-ras-transformed NIH 3T3 cells. Biochem. Biophys. Res Commun., 157: 183-189, 1988.
24. Fotsis, T., Pepper, M., Adlercreutz, H., Fleischmann, G., Hase, T., Montesano, R., and Schweigerer, L. Genistein, a dietary-derived inhibitor of in vitro angiogenesis. Proc. Natl. Acad. Sci. USA, 90 2690-2694, 1993.
25. Kiguchi, K., Constantinou, A. I , and Huberman, E. Genistein-induced cell differentiation and protein-linked DNA strand breakage in human melanoma cells Cancer Commun., 2: 271-278, 1990.
26. Constantinou, A , and Huberman, E. Genistein as an inducer of tumor cell differentiation: possible mechanisms of action. Proc. Soc. Exp. Biol. Med , 208: 109-115, 1995
27. Wei, H., Wei, L , Frenkel, K., Bowen, R , and Barnes, S. Inhibition of tumor promoter-induced hydrogen peroxide formation in vitro and in vivo by genistein. Nutr. Cancer, 20: 1-12, 1993.
28. McCabe, M. J , and Orrenius, S. Genistein induces apoptosis in immature human thymocytes by inhibiting topoisomerase-II. Biochem. Biophys. Res. Commun., 194: 944-950, 1993
29. Spinozzi, F., Pagiacci, M. C , Migliorati, G., Moraca, R., Grignani, F., Riccardi, C., and Nicoletti, I The natural tyrosine kinase inhibitor genistein produces cell cycle arrest and apoptosis in Jurkat T-leukemia cells. Leuk Res., 18: 431-439, 1994
30. Wei, H., Bowen, R., Cai, Q., Barnes, S., and Wang, Y Antioxidant and antipromotional effects of the soybean isoflavone genistein. Proc. Soc. Exp. Biol. Med., 208: 124-130, 1995.
31. Divi, R. L , Chang, H. C., and Doerge, D. R. Anti-thyroid isoflavones from soybean Isolation, characterization, and mechanisms of action Biochem. Pharmacol., 54: 1087-1096, 1997.
32. Kimura, S., Suwa, J., Ito, B., and Sato, H. Development of malignant goiter by defatted soybean with iodine-free diet in rats Gann, 67: 763-765, 1976.
33. Van Wyk, J. J , Arnold, M. B., Wynn, J., and Pepper, F. The effects of a soybean product on thyroid function in humans. Pediatrics, 24: 752-760, 1959
34. Hydovitz, J. D. Occurrence of goiter in an infant on a soy diet. N. Engl. J. Med., 262: 351-353, 1960.
35. Lu, L-J. W., Lin, S-N , Grady, J. J , Nagamani, M., and Anderson, K E. Altered kinetics and extent of urinary daidzein and genistein excretion in women during chronic soya exposure, Nutr. Cancer, 26: 289-302, 1996.
36. Shutt, D A., and Cox, R. I. Steroid and phyto-oestrogen binding to sheep uterine receptors in vitro. J. Endocrinol., 52: 299-310, 1972.
37. Verdeal, K., and Ryan, D. S. Naturally-occurring estrogens in plant foodstuffs - a review. J Food Protect., 42: 577-583, 1979.
38. Zava, D. T., and Duwe, G. Estrogenic and antiproliferative properties of genistein and other flavonoids in human breast cancer cells in vitro. Nutr. Cancer, 27. 31-40, 1997.
39. Wang, C , and Kurzer, M. S. Phytoestrogen concentration determines effects on DNA synthesis in human breast cancer cells. Nutr. Cancer, 28: 236-247, 1997.
40. Hsieh, C. Y , Santell, R. C , Haslam, S. Z., and Helferich, W. G. Estrogenic effects of genistein on growth of estrogen receptor-positive human breast cancer (MCF-7) cells in vitro and in vivo. Cancer Res., 58: 3833-3838, 1998.
41. Kuiper, G. G. J. M , Enmark, E., Pelto-Huikko, M., Nilsson, S , and Gustafsson, J-X Cloning of a novel estrogen receptor expressed in rat prostate and ovary. Proc Natl Acad. Sci. USA, 93: 5925-5930, 1996.
42. Tremblay, G. B , Tremblay, A., Copeland, N. G., Gilbert, D. J., Jenkins, N. A., Labrie, F., and Giguere, V Cloning, chromasomal localization, and functional analysis of the murine estrogen receptor β. Mol. Endocrinol, 11: 353-365, 1997.
43. Mosselman, S., Polman, J., and Dijkema, R. ERβ: identification and characterization of a novel human estrogen receptor. FEBS Lett., 392: 49-53, 1996.
44. Kuiper, G. G. J M., and Gustafsson, J-X. The novel estrogen receptor-β subtype potential role in the cell- and promoter-specific actions of estrogens and anti-estrogens FEBS Lett., 410: 87-90, 1997.
45. Koratkar, R., and Rao, A. V. Effect of soya bean saponins on azoxymethane-induced preneoplastic lesions in the colon of mice. Nutr. Cancer, 27: 206-209, 1997.
46. Rao, A. V., and Sung, M. K Saponins as anticarcinogens. J. Nutr, 125: 717S-724S, 1995.
47. Oakenfull, D., and Sidhu, G S. Could saponins be a useful treatment for hypercholesterolaemia? Eur J. Clin. Nutr., 44: 79-88, 1990.
48. Carroll, K. K , and Kurowska, E M. Soy consumption and cholesterol reduction: review of animal and human studies J. Nutr., 125 594S-597S, 1995.
49. Harwood, H. J, Jr, Chandler, C E., Pellarin, L D., Bangerter, F. W., Wilkins, R. W., Long, C. A., Cosgrove, P. G., Malinow, M, R., Marzetta, C. A., Pettini, J. L., Savoy, Y E., and Mayne, J. T. Pharmacologic consequences of cholesterol absorption inhibition: alteration in cholesterol metabolism and reduction in plasma cholesterol concentration induced by the synthetic saponin β-tigogenin cellobioside (CP-88818; tiqueside). J. Lipid Res., 34 377-395, 1993.
50. Wu, R-T , Chiang, H-C., Fu, W-C , Chien, K-Y , Chung, Y-M., and Horng, L-Y. Formosanin-C, an immunomodulator with antitumor activity. Int. J. Immunopharmacol, 12: 777-786, 1990
51. 1 from Panax Ginseng. Jpn. J Pharmacol., 54: 447-454, 1990.
52. Tokuda, H , Konoshima, T , Kozuka, M , and Kimura, T. Inhibitory effects of 12-O-tetradecanoylphorbol-13-acetate and teleocidin B induced Epstein-Barr virus by saponin and its related compounds. Cancer Lett., 40. 309-317, 1988
53. 2 by cultured B16 melanoma cells. J. Pharm. Sci., 80: 1141-1146, 1991.
54. 2 and adjuvant effects to cisplatin in vivo. Anticancer Drugs, 2: 63-67, 1991.
55. Santiago, L A., Hiramatsu, M., and Mori, A. Japanese soybean paste miso scavenges free radicals and inhibits lipid peroxidation. J. Nutr. Sci Vitaminol 38: 297-304, 1992
56. Deng, H-L., and Zhang, J-T. Anti-lipid peroxilative effect of ginsenoside Rb1 and Rg1. Chin. Med. J., 104 395-398, 1991
57. Anderson, R. L., and Wolf, W. J Compositional changes in trypsin inhibitors, phytic acid, saponins and isoflavones related to soybean processing. J. Nutr., 125: 581S-588S, 1995
58. Oakenfull, D. G., and Sidhu, G. S. Saponins Vol. 2. In. P. Cheeke (ed.), Toxicants of Plant Origin. Boca Raton, FL. CRC Press, 1989.
59. Ishaaya, I , Birk, Y., Bondi, A., and Tencer, Y Soyabean saponins. IX. Studies of their effect on birds, mammals and cold-blooded organisms. J. Sci Food Agric., 20. 433-436, 1969
60. Birk, Y. Protease inhibitors of plant origin and role of protease inhibitors in human nutrition. In: W. Troll and A R Kennedy (eds.), Protease Inhibitors as Cancer Chemopreventive Agents, pp. 97-106 New York: Plenum Publishing Corp., 1993.
61. Kennedy, A. R. Anticarcinogemc activity of protease inhibitors. In: W Troll and A R. Kennedy (eds.), Protease inhibitors as cancer chemopreventive agents, pp. 9-64 New York: Plenum Publishing Corp., 1993.
62. Kennedy, A. R. In vitro studies of anticarcinogenic protease inhibitors. In. W. Troll and A. R Kennedy (eds.), Protease Inhibitors as Cancer Chemopreventive Agents, pp. 65-91. New York: Plenum Publishing Corp, 1993.
63. Baturay, N , and Kennedy, A R. Pyrene acts as a cocarcinogen with the carcinogens, benzo[a]pyrene. β-propiolactone and radiation, in the induction of malignant transformation in cultured mouse fibroblasts: soybean extract containing the Bowman-Birk inhibitor acts as an anticarcinogen. Cell Biol. Toxicol., 2: 21-32, 1986.
64. Yavelow, J , Collins, M., Birk, Y., Troll, W , and Kennedy, A R Nanomolar concentrations of Bowman-Birk soybean protease inhibitor suppress X-ray-induced transformation in vitro. Proc Natl Acad. Sci. USA, 82: 5395-5399, 1985.
65. Billings, P. C , Carew, J. A., Keller-McGandy, C. E., Goldberg, A L , and Kennedy, A R. A serine protease activity in C3H/10TΩ cells that is inhibited by anticarcinogenic protease inhibitors, Proc. Natl. Acad. Sci USA, 84: 4801-4805, 1987.
66. Yavelow, J., Caggana, M., and Beck, K. A Proteases occurring in the cell membrane. a possible receptor for the Bowman-Birk type of protease inhibitors. Cancer Res., 47: 1598-1601, 1987.
67. Kennedy, A R Is there a critical target gene for the first step in carcinogenesis? Environ Health Perspect., 93: 199-203, 1991.
68. Kennedy, A. R Prevention of carcinogenesis by protease inhibitors Cancer Res., 54: 1999S-2005S, 1994.
69. Fahmy, M J , and Fahmy, O G. Intervening DNA insertions and the alteration of gene expression by carcinogens. Cancer Res., 40: 3374-3382, 1980
70. Flick, M. B , and Kennedy, A. R. Effect of protease inhibitors on DNA amplification in SV40-transformed Chinese hamster embryo cells Cancer Lett., 56: 103-108, 1991
71. Kennedy, A R , Szuhaj, B. F., Newberne, P. M., and Billings, P. C. Preparation and production of a cancer chemopreventive agent, Bowman-Birk inhibitor concentrate. Nutr. Cancer, 19. 281-302, 1993.
72. Billings, P. C , Newberne, P. M., and Kennedy, A. R. Protease inhibitor suppression of colon and anal gland carcinogeaesis induced by dimethyl-hydrazine. Carcinogenesis (Lond.), 11: 1083-1086, 1990.
73. von Hofe, E., Newberne, P. M., and Kennedy, A. R. Inhibition of N-nitrosomethylbenzylamine-induced esophageal neoplasms by the Bowman-Birk protease inhibitor. Carcinogenesis (Lond.), 12. 2147-2150, 1991.
74. Witscht, H , and Kennedy, A R. Modulation of lung tumor development in mice with the soybean-derived Bowman-Birk protease inhibitor Carcinogenesis (Lond.), 10. 2275-2277, 1989
75. Kennedy, A. R., Billings, P C , Maki, P. A , and Newberne, P. Effects of various preparations of dietary protease inhibitors on oral carcinogenesis in hamsters induced by DMBA. Nutr Cancer, 19: 191-200, 1993
76. Kennedy, A. R. The evidence for soybean products as cancer preventive agents. J Nutr , 125: 733S-743S, 1995.
77. Messina, M., and Barnes, S. The role of soy products in reducing risk of cancer. J. Natl. Cancer Inst . 83. 541-546, 1991.
78. Yavelow, J., Finlay, T H , Kennedy, A. R., and Troll, W Bowman-Birk soybean protease inhibitor as an anticarcinogen. Cancer Res., 43. 2454S-2459S, 1983
79. Troll, W., Frenkel, K., and Wiesner, R. Protease inhibitors as anticarcinogens. J. Natl. Cancer Inst., 73: 1245-1250, 1984.
80. Shamsuddin, A. M. Inositol phosphates have novel anticancer function J. Nutr, 125: 725S-732S, 1997
81. Graf, E., and Eaton, J. W. Antioxidant functions of phytic acid. Free Radical Biol Med., 8: 61-69, 1990.
82. Graf, E , Mahoney, J R., Bryant, R. G., and Eaton, J W. Iron-catalyzed hydroxyl radical formation Stringent requirement for free iron coordination site. J. Biol. Chem., 259: 3620-3624, 1984.
83. Shamsuddin, A M , Ullah, A , and Chakravarthy, A K. Inositol and inositol hexaphosphate suppress cell proliferation and tumor formation in CD-1 mice. Carcinogenesis (Lond.), 10: 1461-1463, 1989.
84. Zhou, J. R , and Erdman, J. W Phytic acid in health and disease. Crit. Rev. Food Sci. Nutr., 35: 495-507, 1995
85. Champagne, E T., Rao, R M., Liuzzo, J. A , Robinson, J. W., Gale, R. J., and Miller, F. Solubility behaviors of the minerals, proteins, and phytic acid in rice bran with time, temperature, and pH. Cereal Chem., 62: 218-222, 1985.
86. Platt. S. R., and Clydesdale, F M. Interactions of iron, alone and in combination with calcium, zinc and copper, with a phytate-rich, fiber-rich fraction of wheat bran under gastrointestinal pH conditions. Cereal Chem., 64: 102-105, 1987.
87. Ito, A., Goto, T., Okamoto, T., Yamada, K., and Roy, G A combined effect of tamoxifen (Tam) and miso for the development of mammary tumors induced with MNU in SD rats. Proc. Am Assoc. Cancer Res., 37: 271, 1996.
88. Constantinou, A. I., Mehta, R G., and Vaughan, A Inhibition of N-methyl-N-nitrosourea-induced mammary tumors in rats by the soybean isoflavones Anticancer Res., 16: 3293-3298, 1996
89. Constantinou, A., Thomas, C., Mehta, R. G , Runyan, C., and Moon, R. The effect of genistein and daidzein on MNU-induced mammary tumors in rats. Proc. Am. Assoc. Cancer Res., 36: 109-115, 1995.
90. Lamartimere, C A . Moore, J. B , Brown, N M., Thompson, R., Hardin, M J , and Barnes, S. Genistein suppresses mammary cancer in rats. Carcinogenesis (Lond.), 16: 2833-2840, 1995.
91. Murrill, W. B., Brown, N M , Zhang, J. X., Manzolillo, P. A , Barnes, S., and Lamartimere, C. A. Prepubertal genistein exposure suppresses mammary cancer and enhances gland differentiation in rats Carcinogenesis (Lond), 17: 1451-1457, 1996.
92. Kennedy, A. R., Beazer-Barclay, Y., Kinzler, K. W., and Newberne, P. M. Suppression of carcinogenesis in the intestines of Min mice by the soybeanderived Bowman-Birk inhibitor Cancer Res., 56. 679-682, 1996.
93. Steele, V E, Pereira, M. A., Sigman, C. C., and Kelloff, G. J Cancer chemoprevention agent development strategies for genistein. J. Nutr , 125: 713S-716S, 1995
94. Rao, C V , Wang, C-X., Simi, B., Lubet, R., Kelloff, G., Steele, V., and Reddy, B S. Enhancement of experimental colon cancer by genistein. Cancer Res , 57. 3717-3722, 1997.
95. Naik, H R , Lehr, J. E., and Pienta, K J An in vitro and in vivo study of antitumor effects of genistem on hormone refractory prostate cancer Anticancer Res., 14: 2617-2620, 1994
96. Makela, S. I , Pylkkänen, L., Risto, S. S. S., and Adlercreutz, H. Dietary soybean may be antiestrogenic in male mice. J. Nutr., 125: 437-445, 1995.
97. Pollard, M , and Luckert, P. H. Influence of isoflavones in soy protein isolates on development of induced prostate-related cancers in L-W rats Nutr Cancer, 28. 41-45, 1997.
98. Zhang. J-X., Hallmans, G., Landström, M., Bergh, A., Damber, J-E., Xman, P., and Adlercreutz, H. Soy and rye diets inhibit the development of Dunning R3327 prostatic adenocarcinoma in rats. Cancer Lett , 114: 313-314, 1997
99. Lee, K. W., Wang, H. J., Murphy, P. A., and Hendrich, S. Soybean isoflavone extract suppresses early but not later promotion of hepatocarcinogenesis by phenobarbital in female rat liver. Nutr Cancer, 24: 267-278, 1995.
100. Menon, L. G., Kuttan, R., Nair, M. G , Chang, Y-C., and Kuttan, G. Effect of isoflavones genistein and daidzein in the inhibition of lung metastasis in mice induced by B16F-10 melanoma cells. Nutr. Cancer, 30: 74-77, 1998.
101. Lee, H P., Gourley, L., Duffy, S. W., Estève, J., Lee, J., and Day, N. E. Dietary effects on breast-cancer risk in Singapore. Lancet, 337: 1197-1200, 1991
102. Severson, R. K., Nomura, A. M. Y., Grove, J. S., and Stemmermann, G. N. A prospective study of demographics, diet, and prostate cancer among men of Japanese ancestry in Hawaii Cancer Res., 49: 1857-1860, 1989.
103. Hirayama, T. Epidemiology of stomach cancer in Japan. Jpn. J. Clin. Oncol., 14. 159-168, 1984.
104. Tajima, K., and Tominaga, S Dietary habits and gastro-intestinal cancers: a comparative case-control study of stomach and large intestine cancers in Nagoya, Japan Jpn J. Cancer Res., 76: 705-716, 1985.
105. Koo, L. C. Dietary habits and lung cancer risk among Chinese females in Hong Kong who never smoked Nutr Cancer, 11: 155-172, 1988
106. Goodman, M. T., Hankin, J. H., Wilkens, L. R , Lyu, L-C., McDuffie, K., Liu, L. Q , and Kolonel, L N. Diet, body size, physical activity, and the risk of endometrial cancer. Cancer Res., 57: 5077-5085, 1997.
107. Cassidy, A. Physiological effects of phyto-oestrogens in relation to cancer and other human health risks Proc. Nutr. Soc., 55: 399-417, 1996.
108. Ingram, D., Sanders, K., Kolybaba, M., and Lopez, D. Case-control study of phyto-estrogens and breast cancer. Lancet, 350: 990-994, 1997.
109. Adlercreutz, H , Fotsis, T., Bannwart, C., Wahala, K., Makela, T., Brunow, G., and Hase, T. Determination of urinary lignans and phytoestrogen metabolites, potential antiestrogens and anticarcinogens, in urine of women on various habitual diets. J. Steroid Biochem., 25: 791-797, 1986.
110. Adlercreutz, H, Honjo, H., Higashi, A., Fotsis, T., Hämäläinen, E., Hasegawa, T., and Okada, H Urinary excretion of lignans and isoflavonoid phytoestrogens in Japanese men and women consuming a traditional Japanese diet. Am J Clin. Nutr., 54 1093-1100, 1991.
111. Lu, L. J., Hokanson, J. A., Anderson, K. E., Marshall, M. V , Hu. D. M., Kinsky, M. P., and Sadagopa Ramanujum, V M. Urinary excretion of isoflavones in healthy subjects after soymilk consumption. Proc. Am Assoc. Cancer Res., 34: 556, 1993.
112. Hutchins, A. M., Slavin, J L., and Lampe, J. W Soybean feeding and urinary isoflavonoid phytoestrogen and lignan excretion in healthy men. J. Nutr., 125: 802S, 1995.
113. Franke, A A., Custer, L J., Cerna, C. M, and Narala, K. Rapid HPLC analysis of dietary phytoestrogens from legumes and from human urine. Proc. Soc Exp. Biol. Med., 208: 18-26, 1995.
114. Franke, A. A., and Custer, L J. High-performance liquid chromatographic assay of isoflavonoids and coumestrol from human urine. J Chromatogr. B. Biomed. Appl., 662: 47-60, 1994
115. Kelly, G. E , Nelson, C , Waring, M A , Joannou, G. E , and Reeder, A. Y Metabolites of dietary (soya) isoflavones in human urine. Clin. Chim. Acta, 223: 9-22, 1993.
116. Karr, S. C., Lampe, J. W., Hutchins, A. M., and Slavin, J. L. Urinary isoflavonoid excretion in humans is dose dependent at low to moderate levels of soy-protein consumption. Am. J Clin. Nutr, 66: 46-51, 1997
117. Franke, A. A. Correspondence re. L-J. W. Lu et al., A simplified method to quantify isoflavones in commercial soybean diets and human urine after legume consumption. Cancer Epidemiol., Biomarkers & Prev , 4: 497-503, 1995. Cancer Epidemiol. Biomark Prev., 5. 407-408, 1996.
118. Franke, A. A. Correspondence re. L-J. W. Lu et al., A simplified method to quantify isoflavones in commercial soybean diets and human urine after legume consumption. Cancer Epidemiol., Biomarkers & Prev , 4: 497-503, 1995. Cancer Epidemiol. Biomark Prev., 5. 407-408, 1996.
119. Gooderham, M. H., Adlercreutz, H., Ojala, S. T., Wähäla, K , and Holub, B. J. A soy protein isolate rich in genistein and daidzein and its effects on plasma isoflavone concentrations, platelet aggregation, blood lipids and fatty acid composition of plasma phospholipid in normal men. J Nutr., 126: 2000-2006, 1996.
120. Franke, A. A., Custer, L. J., Wang, W , and Shi, C. Y. HPLC analysis of isoflavonoids and other phenolic agents from foods and from human fluids. Proc. Soc. Exp. Biol. Med., 217: 263-273, 1998.
121. Lamartiniere, C. A , Murrill, W , and Brown, N. Chemoprevention of breast cancer with the soy component, genistein. Proc. Annu. Meet. Am. Assoc. Cancer Res., 36: A352S, 1995.
122. Sfakianos, J., Coward, L., Kirk, M., and Barnes, S Intestinal uptake and biliary excretion of the isoflavone genistein in rats. J. Nutr., 127: 1260-1268, 1997.
123. Zava, D. T , and Duwe, G Estrogenic reactivity of phytoestrogens in human breast cancer cells in microlayer cultures J. Nutr., 125: 807S, 1995.
124. Cassidy, A , Bingham, S., and Setchell, K. D. R. Biological effects of a diet of soy protein rich in isoflavones on the menstrual cycle of premenopausal women. Am J Clin. Nutr , 60: 333-340, 1994.
125. Lu, L-J. W., Anderson, K. E., Grady, J. J., and Nagamam. M Effects of soya consumption for one month on steroid hormones in premenopausal women: implications for breast cancer risk reduction. Cancer Epidemiol. Biomark. Prev., 5: 63-70, 1996.
126. Sauter, E R., Ross, E, Daly, M., Klein-Szanto, A , Engstrom, P. F., Sorling, A , Malick, J, and Ehya, H. Nipple aspirate fluid: a promising non-invasive method to identify cellular markers of breast cancer risk. Br. J Cancer, 76: 494-501, 1997
127. Sauter, E. R., Daly, M., Linahan, K , Ehya, H., Engstrom, P. F., Bonney, G., Ross, E. A, Yu, H., and Diamandis, E Prostate-specific antigen levels in nipple aspirate fluid correlate with breast cancer risk. Cancer Epidemiol. Biomark. Prev., 5. 967-970, 1996
128. Petrakis, N. L., Barnes, S , King, E. B., Lowenstein, J , Wiencke, J., Lee, M. M., Miikc, R , Kirk, M., and Coward, L. Stimulatory influence of soy protein isolate on breast fluid secretion in pre- and postmenopausal women. Cancer Epidemiol Biomark. Prev., 5: 785-794, 1996.
129. Fiel, M. I., Cernaianu, G., Burstein, D. E, and Batheja, N. Value of GCDFP-15 (BRST-2) as a specific immunocytochemical marker for breast carcinoma in cytologic specimens. Acta Cytol., 40: 637-641, 1996
130. Kaufmann, O , Deidesheimer, T., Muehlenberg, M., Deicke, P., and Dietel, M Immunohistochemical differentiation of metastatic breast carcinomas from metastatic adenocarcinomas of other common primary sites. Histopathology, 29. 233-240, 1996.
131. Haagensen, D. E., Kelly, D., and Bodian, C. A. GCDFP-15 blood levels for stratification of risk of breast cancer development in women with active breast gross cystic disease. Breast, 6: 113-119, 1997
132. McMichael-Philips, D E., Harding, C., Morton, M., Potten, C. S., and Bundred, N. J. The effects of soy supplementation on epithelial proliferation in the normal human breast Am. J. Clin. Nutr., in press, 1998.
133. Kelloff, G J , and Boone, C W. (eds.). NCI clinical development plan: genistein. J. Cell. Biochem., 265: 114-126, 1996.
134. Barnes, S., Sfakianos, J., Coward, L., and Kirk, M. Soy isoflavonoids and cancer prevention. Underlying biochemical and pharmacological issues. Adv. Exp Med. Biol., 401 87-100, 1996
135. Adlercreutz, H., Markkanen, H., and Watanabe, S. Plasma concentrations of phyto-oestrogens in Japanese men. Lancet, 342: 1209-1210, 1993
136. Madar, Z, Gertler, A., and Birk, Y. The fate of Bowman-Birk trypsin inhibitor from soybeans in the digestive tract of chicks. Comp. Biochem. Physiol., 62A. 1057-1061, 1979.
137. Fontham, E., and Correa, P. The epidemiologic approach to the study of protease inhibitors. In: W Troll and A. R. Kennedy (eds), Protease inhibitors as cancer chemopreventive agents, pp. 1-8. New York. Plenum Publishing Corp , 1993.
138. Kennedy, A. R. In vitro studies of anticarcinogenic protease inhibitors. In: W. Troll and A. R. Kennedy (eds), Protease inhibitors as chemopreventive agents, pp. 65-91. New York: Plenum Publishing Corp , 1993.